Skip to main content

Published locations for FDA approves abiraterone acetate for metastatic high-risk CSPC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves abiraterone acetate for metastatic high-risk CSPC

User login

  • Reset your password
  • /content/fda-approves-abiraterone-acetate-metastatic-high-risk-cspc
  • /oncologypractice/article/158223/genitourinary-cancer/fda-approves-abiraterone-acetate-metastatic
  • /hematology-oncology/article/158223/genitourinary-cancer/fda-approves-abiraterone-acetate-metastatic